Suzhou Leadsynbio: CSRC Files Overseas Issuance and Listing and "Full Circulation" Application, Plans to Issue up to 18.27 Million H Shares

NewTimeSpace News: The China Securities Regulatory Commission (CSRC) has issued a filing notice for overseas issuance and listing, under which Suzhou Leadsynbio Technology Co., Ltd. proposes to issue no more than 18,271,600 overseas listed ordinary shares for listing on The Stock Exchange of Hong Kong Limited.

According to the filing notice, 27 shareholders of the Company propose to convert an aggregate of 47,665,277 domestic unlisted shares into overseas listed shares for listing and trading on the Stock Exchange of Hong Kong, i.e., the application for "full circulation" of domestic unlisted shares of H share companies.

The filing notice requires that: the Company report any major matters through the CSRC's filing management information system from the date of the notice until the completion of the overseas issuance and listing; report the details of the issuance and listing within 15 working days after completion; and update the filing materials if the overseas issuance, listing and share conversion are not completed within 12 months from the date of the notice and the Company intends to proceed. The notice only confirms the filing information and does not constitute a substantive judgment or guarantee by the CSRC as to the investment value of the securities or the returns of investors.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.